Mira Jung - May 1, 2024 Form 4 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Role
Chief Scientific Officer
Signature
/s/ Mira Jung
Stock symbol
SHPH
Transactions as of
May 1, 2024
Transactions value $
-$6,745
Form type
4
Date filed
10/9/2024, 05:00 PM
Previous filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SHPH CLASS A COMMON STOCK Award -$6.75K -598 -0.44% $11.28 136K May 1, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person received a grant of 1,791 restricted stock units ("RSUs") on May 1, 2023 (14,326 RSUs on a pre-reverse split basis), which RSUs are subject to vesting over a period of three years. The first vesting of 598 RSUs occurred on May 1, 2024.
F2 Consists of (i) 134,522 shares of common stock and (ii) 1,193 RSUs which remain subject to vesting. All share and RSU numbers reflect a 1-for-8 reverse stock split effected by the issuer on August 13, 2024.